284 related articles for article (PubMed ID: 26028294)
1. Anle138b and related compounds are aggregation specific fluorescence markers and reveal high affinity binding to α-synuclein aggregates.
Deeg AA; Reiner AM; Schmidt F; Schueder F; Ryazanov S; Ruf VC; Giller K; Becker S; Leonov A; Griesinger C; Giese A; Zinth W
Biochim Biophys Acta; 2015 Sep; 1850(9):1884-90. PubMed ID: 26028294
[TBL] [Abstract][Full Text] [Related]
2. Photophysics of diphenyl-pyrazole compounds in solutions and α-synuclein aggregates.
Reiner AM; Schmidt F; Ryazanov S; Leonov A; Weckbecker D; Deeg AA; Griesinger C; Giese A; Zinth W
Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):800-807. PubMed ID: 29273222
[TBL] [Abstract][Full Text] [Related]
3. Anle138b interaction in α-synuclein aggregates by dynamic nuclear polarization NMR.
Dervişoğlu R; Antonschmidt L; Nimerovsky E; Sant V; Kim M; Ryazanov S; Leonov A; Fuentes-Monteverde JC; Wegstroth M; Giller K; Mathies G; Giese A; Becker S; Griesinger C; Andreas LB
Methods; 2023 Jun; 214():18-27. PubMed ID: 37037308
[TBL] [Abstract][Full Text] [Related]
4. Resolving the Atomistic Modes of Anle138b Inhibitory Action on Peptide Oligomer Formation.
Matthes D; Gapsys V; Griesinger C; de Groot BL
ACS Chem Neurosci; 2017 Dec; 8(12):2791-2808. PubMed ID: 28906103
[TBL] [Abstract][Full Text] [Related]
5. The clinical drug candidate anle138b binds in a cavity of lipidic α-synuclein fibrils.
Antonschmidt L; Matthes D; Dervişoğlu R; Frieg B; Dienemann C; Leonov A; Nimerovsky E; Sant V; Ryazanov S; Giese A; Schröder GF; Becker S; de Groot BL; Griesinger C; Andreas LB
Nat Commun; 2022 Sep; 13(1):5385. PubMed ID: 36104315
[TBL] [Abstract][Full Text] [Related]
6. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.
Wagner J; Ryazanov S; Leonov A; Levin J; Shi S; Schmidt F; Prix C; Pan-Montojo F; Bertsch U; Mitteregger-Kretzschmar G; Geissen M; Eiden M; Leidel F; Hirschberger T; Deeg AA; Krauth JJ; Zinth W; Tavan P; Pilger J; Zweckstetter M; Frank T; Bähr M; Weishaupt JH; Uhr M; Urlaub H; Teichmann U; Samwer M; Bötzel K; Groschup M; Kretzschmar H; Griesinger C; Giese A
Acta Neuropathol; 2013 Jun; 125(6):795-813. PubMed ID: 23604588
[TBL] [Abstract][Full Text] [Related]
7. Treatment with diphenyl-pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death.
Turriani E; Lázaro DF; Ryazanov S; Leonov A; Giese A; Schön M; Schön MP; Griesinger C; Outeiro TF; Arndt-Jovin DJ; Becker D
Proc Natl Acad Sci U S A; 2017 Jun; 114(25):E4971-E4977. PubMed ID: 28584093
[TBL] [Abstract][Full Text] [Related]
8. α-Synuclein aggregation at low concentrations.
Afitska K; Fucikova A; Shvadchak VV; Yushchenko DA
Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):701-709. PubMed ID: 31096048
[TBL] [Abstract][Full Text] [Related]
9. DJ-1, a Parkinson's disease related protein, aggregates under denaturing conditions and co-aggregates with α-synuclein through hydrophobic interaction.
Zhu M; H Patel S; Han S
Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1759-1769. PubMed ID: 28330770
[TBL] [Abstract][Full Text] [Related]
10. One-Pot Radiosynthesis of [
Orlovskaya VV; Fedorova OS; Viktorov NB; Vaulina DD; Krasikova RN
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985703
[TBL] [Abstract][Full Text] [Related]
11. Discovery of small molecule benzothiazole and indole derivatives tackling tau 2N4R and α-synuclein fibrils.
Elbatrawy AA; Ademoye TA; Alnakhala H; Tripathi A; Zami A; Ostafe R; Dettmer U; Fortin JS
Bioorg Med Chem; 2024 Feb; 100():117613. PubMed ID: 38330847
[TBL] [Abstract][Full Text] [Related]
12. Molecular docking analysis of α-Synuclein aggregation with Anle138b.
Grewal A; Sheokand D; Saini V; Kumar A
Bioinformation; 2024; 20(3):217-222. PubMed ID: 38711999
[TBL] [Abstract][Full Text] [Related]
13. Anle138b modulates α-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy.
Heras-Garvin A; Weckbecker D; Ryazanov S; Leonov A; Griesinger C; Giese A; Wenning GK; Stefanova N
Mov Disord; 2019 Feb; 34(2):255-263. PubMed ID: 30452793
[TBL] [Abstract][Full Text] [Related]
14. Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial.
Levin J; Sing N; Melbourne S; Morgan A; Mariner C; Spillantini MG; Wegrzynowicz M; Dalley JW; Langer S; Ryazanov S; Leonov A; Griesinger C; Schmidt F; Weckbecker D; Prager K; Matthias T; Giese A
EBioMedicine; 2022 Jun; 80():104021. PubMed ID: 35500536
[TBL] [Abstract][Full Text] [Related]
15. Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein.
Ahsan N; Mishra S; Jain MK; Surolia A; Gupta S
Sci Rep; 2015 May; 5():9862. PubMed ID: 25985292
[TBL] [Abstract][Full Text] [Related]
16. Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors.
Jha NN; Kumar R; Panigrahi R; Navalkar A; Ghosh D; Sahay S; Mondal M; Kumar A; Maji SK
ACS Chem Neurosci; 2017 Dec; 8(12):2722-2733. PubMed ID: 28872299
[TBL] [Abstract][Full Text] [Related]
17. Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance.
Lemos M; Venezia S; Refolo V; Heras-Garvin A; Schmidhuber S; Giese A; Leonov A; Ryazanov S; Griesinger C; Galabova G; Staffler G; Wenning GK; Stefanova N
Transl Neurodegener; 2020 Sep; 9(1):38. PubMed ID: 32972456
[TBL] [Abstract][Full Text] [Related]
18. NADH fluorescence lifetime is an endogenous reporter of α-synuclein aggregation in live cells.
Plotegher N; Stringari C; Jahid S; Veronesi M; Girotto S; Gratton E; Bubacco L
FASEB J; 2015 Jun; 29(6):2484-94. PubMed ID: 25713058
[TBL] [Abstract][Full Text] [Related]
19. Investigation of α-Synuclein Amyloid Fibrils Using the Fluorescent Probe Thioflavin T.
Sulatskaya AI; Rodina NP; Sulatsky MI; Povarova OI; Antifeeva IA; Kuznetsova IM; Turoverov KK
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142878
[TBL] [Abstract][Full Text] [Related]
20. Gallic acid interacts with α-synuclein to prevent the structural collapse necessary for its aggregation.
Liu Y; Carver JA; Calabrese AN; Pukala TL
Biochim Biophys Acta; 2014 Sep; 1844(9):1481-5. PubMed ID: 24769497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
